Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Observer-Blind, Dose Escalation, Placebo-Controlled, Phase 1 Clinical Trial to Study the Safety and Immunogenicity of a COVAC-1 Booster Dose in Generally Healthy Adults

NCT05693272 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.

NCT NCT05693272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05693272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Observer-Blind, Dose Escalation, Placebo-Controlled, Phase 1 Clinical Trial to Study the Safety and Immunogenicity of a COVAC-1 Booster Dose in Generally Healthy Adults
Lead sponsor
University of Saskatchewan
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2023
Completion date
June 4, 2024
Enrollment
47 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

severe acute respiratory syndrome coronavirus 2 infection